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Summary
A decline in skeletal muscle mass and function with aging is well
recognized, but remains poorly characterized at the molecular
level. Here, we report for the first time a genome-wide study of
DNA methylation dynamics in skeletal muscle of healthy male
individuals during normal human aging. We predominantly
observed hypermethylation throughout the genome within the
aged group as compared to the young subjects. Differentially
methylated CpG (dmCpG) nucleotides tend to arise intragenically
and are underrepresented in promoters and are overrepresented
in the middle and 3′ end of genes. The intragenic methylation
changes are overrepresented in genes that guide the formation
of the junction of the motor neuron and myofibers. We report a
low level of correlation of gene expression from previous studies
of aged muscle with our current analysis of DNA methylation
status. For those genes that had both changes in methylation and
gene expression with age, we observed a reverse correlation,
with the exception of intragenic hypermethylated genes that
were correlated with an increased gene expression. We suggest
that a minimal number of dmCpG sites or select sites are required
to be altered in order to correlate with gene expression changes.
Finally, we identified 500 dmCpG sites that perform well in
discriminating young from old samples. Our findings highlight
epigenetic links between aging postmitotic skeletal muscle and
DNA methylation.
Key words: DNA methylation; skeletal muscle; human aging;
epigenome; genomics; postmitotic.
Introduction
Aging is accompanied by a reduction in muscle mass and function,
which is commonly referred to as sarcopenia and leads to decreased
mobility (Marzetti et al., 2009), with an estimated cost to the US
economy of some 18.5 billion a year (Janssen et al., 2004). Although
numerous different biochemical pathways have been linked with
sarcopenia, the mechanisms that drive the development of this
important age-related disorder remain to be uncovered. There have
been several studies focused at the molecular level that have reported
changes in skeletal muscle with age and exercise. However, these studies
have primarily focused on the quantitation of RNA abundance (Melov
et al., 2007; Drummond et al., 2011) or have not stringently controlled
for confounding effects such as activity level, comorbidities, medications,
and timing of the last exercise bout. In addition to measuring gene
expression, the epigenetic modification of DNA cytosine plays important
roles in many processes including differentiation and cellular senescence
(Berdasco & Esteller, 2011). Aging cells, different tissue types as well as a
variety of human diseases possess their own distinct DNA methylation
profiles (Fernandez et al., 2012). Dysregulation of DNA methylation has
also been reported with age-related disorders such as Alzheimer’s
disease (Irier & Jin, 2012) and cancer (Lopez-Serra & Esteller, 2012).
Changes in DNA methylation with aging have also been reported in a
select few tissues of human beings, as well as in a number of other
species (Calvanese et al., 2009). One of the initial studies reported a
decline in methylation in a number of aged mouse tissues (Wilson et al.,
1987). Another early study observed promoter hypermethylation with
age in human colorectal mucosa and argued that aging is a major
contributing factor to hypermethylation in cancer of this tissue (Ahuja
et al., 1998). A longitudinal study of DNA methylation in human blood
cells reported that DNA methylation changes with age (Bjornsson et al.,
2008). A recent report compared global hypomethylation of DNA from
blood in centenarians with middle-aged individuals and newborns (Heyn
et al., 2012). However, in general, molecular studies on aged tissues
from well-characterized cohorts absent of potentially confounding age-
related disorders are relatively uncommon. The majority of DNA
methylation studies on aging have been carried out on blood comprised
of multiple cell types. No studies have as of yet examined postmitotic
skeletal muscle for epigenetic changes between young and old
individuals. A minor surgical procedure is required to obtain such
tissues, contributing to the difficulty in carrying out such studies.
Here, we report for the first time a genome-wide study of DNA
methylation dynamics in a postmitotic tissue – skeletal muscle taken
from healthy older adults compared to young adults under controlled
conditions at over 480 000 sites throughout the genome. We report a
predominant pattern of hypermethylation in the DNA of aging skeletal
muscle. Surprisingly, the locations of these dmCpG sites are underrep-
resented in promoter regions and are overrepresented in the middle and
3′ ends of genes. These epigenetic changes could be very significant to
the biology of aging muscle as recent studies have suggested that age-
related loss of muscle mass is not due to the loss of muscle cells, but a
reduction in type II fiber size (Nilwik et al., 2013). In comparing our data
with prior gene expression studies, we did not observe a general
correlation of DNA methylation with differentially expressed genes in
aged human skeletal muscle. Finally, using a novel approach to identify
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dmCpGs associated with aging, we have identified over 500 methylated
sites that separate younger subjects from older subjects in this study.
Results
Distribution of differentially methylated CpG sites
We have studied DNA methylation dynamics in skeletal muscle taken
from 24 healthy older male adults (age range: 68–89 years) compared to
24 young male adults (age range: 18–27 years) under controlled
conditions at 485 577 sites throughout the genome (Illumina 450 K
methylation arrays). We found an overall global trend of genomic
hypermethylation in human skeletal muscle between the young and old
groups (Fig. 1). We identified 5963 CpG sites that are differentially
methylated between the two groups (dmCpG). Of these, 92% (5518
dmCpG sites) were hypermethylated in the older subjects, while the
remaining 8% were hypomethylated (Table S1, Supporting Information).
We observed that the distribution of dmCpG sites was relatively even
over all chromosomes, with exceptions of a significant overrepresenta-
tion of dmCpGs in chromosomes 16, 17 and a relative underrepresen-
tation in the X chromosome (Table S2, Supporting Information). For both
hyper- and hypomethylated dmCpG sites, there was a significant
enrichment within a gene and there was an underrepresentation outside
of genes (Fig. 2A, Table S2). In order to further refine positional
information about dmCpGs with age relative to gene structure, we
segmented genes into the following structural regions: the 5′ region, the
‘central’ region, the 3′ region, and regions around the transcription start,
and end sites (TSS and TES). DmCpG sites within genes could be divided
into two broad regions – those that were underrepresented near the 5′
regions of genes and those that were enriched in the central and 3′
regions (Fig. 2B, Table S2).
CpG islands (CGI) are present in 60% of gene promoters in the 450 K
chip, and methylation deregulation in CGI overlapping the promoter has
often been linked with cancer (Draht et al., 2012). Other relevant
features of note in the methylated DNA of cancer are increases in the
inter- and intragenic CGI (Deaton et al., 2011) and CGI shores (Irizarry
et al., 2009). In order to examine whether a similar phenomenon arises
in aged human skeletal muscle, we tested the association between
methylation and age in CGI and CGI shores (2000 base pairs upstream
and downstream of a CGI) that overlap with promoters, and intra-/
intergenic regions. We determined that in aging human skeletal muscle,
there is an overall enrichment of dmCpG sites in CGI shores and there is
a decrease in CGI, except for CGI within a gene (Fig. 2C, Table S2). All
data including methylation values/subject, and methylated vs. unmethy-
lated probe data, are deposited in GEO and are accessible via the GEO
number GSE50498.
Recently, it was determined that an R-loop (a three-stranded nucleic
acid structure formed due to biased strand distribution of guanines and
cytosines, or GC-skew) negatively correlates with the corresponding
promoter methylation level (Ginno et al., 2012). For each promoter
region (1500 +1500 bp around TSS), we defined those that have or do
not have CGI or GC-skew, or both. We identified that there was an
underrepresentation of dmCpG sites in all promoters, unless it is a
promoter with no CGI and nonskew (Fig. 2D, Table S2). Ginno et al.
reported that promoters with CGI and positive GC-skew are the most
protected from methylation, while as promoters with weak CGI and
weak GC-skew showed little to no protection. Concordant with these
results, we report that less protected promoters in DNA of aged skeletal
muscle tend to acquire more methylation than the younger tissue.
As a final analysis of the positional information of the dmCpG sites
within aged skeletal muscle, we performed an analysis for possible
enrichment of differential methylation of transcriptional regulator-
binding sites. Using the ENCODE ChIP-Seq Significance Tool, we were
able to probe existing datasets for enriched transcription factors within
our gene list (Auerbach et al., 2013). We used all skeletal muscle cell
lines (Hsmm, Hsmmt) available within the ENCODE project and then
analyzed gene sets from our data that have at least 2, 4, or 8 dmCpG
within their gene boundaries. In all three cases, the only significantly
enriched motif (P < 0.01) was the transcription factor CTCF (Table S3,
Supporting Information).
Genes with altered methylation status within aged muscle
tissue
We identified 2114 genes with at least one dmCpG site located
intragenically (Table S4, Supporting Information) in DNA from aged
skeletal muscle. The location of these dmCpG sites may be significant, as
methylation changes in aged individuals may affect gene function
(Maunakea et al., 2010) and consequently muscle function. We
observed that the number of dmCpG sites for a gene was not
dependent on the total number of CpG sites present on the microarray
chip for the same gene (Pearson’s correlation = 0.55, and Fig. S1,
Supporting Information). One example of a gene with dmCpG that is
affected by aging is the tubulin-folding cofactor D (TBCD) gene (Fig. 3).
Tubulin-folding cofactor D has the highest number of intragenic dmCpG
sites (46 distinct sites, which is 13.2% of the total number of CpG sites
present for the gene). Of these, 45 of them were hypermethylated in the
aged group compared to the young muscle tissue, a significant
enrichment in the older age group. As an important component of
microtubules, TBCD plays a key role in all cell types, and disruption of
microtubule pathways was previously reported to affect motor neuron
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Fig. 1 Changes in methylation status with age. Distribution of the t-statistic
shows a significant hypermethylation of DNA derived from skeletal muscle of older
versus younger adults (distribution is shifted to the right). Y-axis: number of CpG
probes; x-axis: t-statistic. Filled columns are hypermethylated with age, and
uncolored columns hypomethylated with age.
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function (Molon et al., 2004). Another interesting example of dmCpG
within the older age group is the gene for pericentrin, with three dmCpG
sites. We report that all three of these sites were hypomethylated with
age (4.1% of total), and expression of this gene has also been reported
to be increased with age (Melov et al., 2007). Like TBCD, the pericentrin
protein is a part of the cytoskeleton, and it plays an important role in
microtubule assembly and reorganization during muscle differentiation
(Bugnard et al., 2005).
Ontology and pathway enrichment analysis
In order to better understand the biological significance of dmCpG
changes in aged skeletal muscle, we applied STOP, an ontology
enrichment tool (Wittkop et al., 2013), to genes with two or more
intragenic dmCpG sites. Only one enriched term was found from cell
type ontology analysis, the term ‘muscle cell’ (P = 0.0004). This suggests
that the dmCpG sites we identified within the aged group are relevant to
muscle tissue. There were 54 enriched terms with a P < 0.01 (Table S5,
Supporting Information). This list includes muscle-related terms (two
terms) and signal transduction/intracellular transport (25 terms), such as
axon (P = 2.05E-07) and axon guidance (P = 2.11E-07), which may be
related to muscle innervation and aging. A decline of function in the
neuromuscular junction has long been thought to contribute to the
decline of muscle mass with age (B€utikofer et al., 2011). Actin
cytoskeleton (P = 3.89E-05), cytoskeleton (P = 0.0003), and cytoskele-
ton organization (P = 0.001) are all linked to cytoskeleton function, and
the latter plays an important role in proper muscle contractile function
(Berthier & Blaineau, 1997). Other significantly identified terms could be
put together into the cell adhesion/motility group (six terms), including
plasma membrane (P = 3.23E-08), homophilic cell adhesion (P = 8.43E-
08), and cell adhesion (P = 1.70E-05), with cell adhesion being associ-
ated with fiber degeneration (Campbell, 1995). Additionally, we
observed several terms that could be gathered into a growth and
differentiation group (six terms), ion binding (two terms), broad cellular
function (11 terms), and two terms that stand separately.
We further expanded our analysis by examining the overrepresenta-
tion of canonical genetic pathways specific to muscle tissue using
ingenuity pathway analysis (www.ingenuity.com) (Table S6, Supporting
Information). This analysis further expanded on the STOP ontology
evaluation by identifying ‘axon guidance signaling’ as the top pathway
within the dmCpG dataset (P = 6.16E-10) with 50 of 216 pathway
members (23.1%) differentially methylated in at least one intragenic site
(Table S7 and Fig. S2, Supporting Information).
A recent report utilized genes identified as having dmCpGs with age
to examine stem cell differentiation pathways (West et al., 2013). We
compared our results from postmitotic skeletal muscle to their findings
of the best age predictor in whole blood – the UTF1 gene, which is also
hypermethylated with age. We did not find any dmCpG sites within or
around this gene in DNA obtained from skeletal muscle. We also did not
observe dmCpG sites in/around the other age predictors WNT3A, SFRP1,
FZD2, or FZD9 previously reported for whole blood. Another study of
DNA methylation of whole blood and aging found a hypermethylation of
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bivalent chromatin domains with increasing age (Rakyan et al., 2010).
The comparison of the sites from that study and our current study of
skeletal muscle found that there was a significant overlap in genes that
contain both dmCpG sites in bivalent chromatin domains (hypergeo-
metric test, P = 7E-33).
Comparison of DNA methylation state with gene expression
Next, we compared the differentially methylated sites identified in DNA
from aged skeletal muscle with a previously reported study on gene
expression using a similar experimental design, which was focused on
healthy older adults absent age-related disease (Melov et al., 2007). We
could not carry out gene expression and genome-wide methylation on
all samples, as the amount of material obtained via needle biopsy was
limited at the time we carried out the study. We wished to determine
whether there was any relationship between gene expression in healthy
aged skeletal muscle and the level of DNA methylation. We identified
suites of genes that have a minimum number of differentially methylated
CpG sites (1, 2, 4, 8, and 16) within specific regions, for example
intragenic, 5′ end, or CGI-TSS. If a gene has only hypermethylated or
hypomethylated sites, it was designated as such. We then calculated the
number of genes from either hypo- or hypermethylated groups that
overlap with genes that were previously reported to be overexpressed or
underexpressed within aged muscle tissue, as well as genes that did not
change in expression between young and old subjects. We determined
that the majority of genes with altered methylation in DNA from healthy
aged human skeletal muscle are characterized by unchanged gene
expression within aged tissue (Table S8, Supporting Information).
We then focused only on genes that were significantly altered in the
aged group as compared to the young group, and calculated how
changes in gene expression correlate with changes in DNA methylation.
We found that a majority of hypomethylated genes had an increase in
gene expression with age, while hypermethylated genes displayed a
reduction in gene expression (Fig. 4). Only for dmCpG sites in the 3′ ends
of genes did we observe a positive concordance between hypermethy-
lation and up-regulation of gene expression, which has also been
reported by other groups in differing biological contexts (Hellman &
Chess, 2007; Feng et al., 2010). These correlations were especially
strong with increasing numbers of dmCpG sites within a gene or gene
region. These results suggest that a minimal number of dmCpG sites or
select sites are required to be altered in order to inversely modulate the
gene expression in aging skeletal muscle. Similar results were also
reported for different tissues in another methylation study (Weber et al.,
2007).
Differential methylation sites with age
From all dmCpG in DNA from aged skeletal muscle, there are 500 high
probability predicting CpG sites (Table S9, Supporting Information) and
21 CpG sites that are universally changed in either the young or old age
groups’ CpG predictors (i.e., either all increased in all old samples, and all
decreased in all young samples, or the inverse) (Fig. 5). We used a
procedure in which cross-validation was used to estimate the misclas-
sification rate. It also incorporates simple stepwise constant functions as
candidates and will result in no misclassified samples (see methods for a
more detailed description). A majority of these sites are increased in
methylation within the aged tissue, although some do decrease. Any
reasonable prediction procedure that looks for simple cutoffs using even
one probe comparing young samples to old samples would have found
probes that completely cross-validated (unbiased) in terms of classifying
young from old in 21 of the sites, and nearly completely separated young
from old for at least 500. Three probes of these 21 sites are excellent at
distinguishing young from old, and nine of 500 of these excellent/good
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Fig. 4 Correspondence of hyper- and hypo-dmCpG in genes with changes in
gene expression. Number of genes (x-axis) that have a minimal number of
hypermethylated (A) or hypomethylated dmCpG (B). The data are displayed as a
stacked bar chart for one probe (red), two probes (green), or four probes (blue) for
each genome position category. The expression change in aged tissue is indicated
as bars. Left of axis is down-regulated and bars to the right are up-regulated.
Detailed description of genome position categories is described in Table S12.
Fig. 5 Methylation level of 21 CpG probes with M-values ranked by age.
Individual methylation levels of 21 CpG sites that distinguish young from old
subjects.
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predictors were also determined as age-predicting markers by a recent
study on DNA methylation in blood (Hannum et al., 2012) (Table S10,
Supporting Information). However, we stress that such sites would need
to be validated in a completely independent population in order to verify
their biological significance, although it remains statistically highly
unlikely that these 21 probes are differentially methylated between the
two age groups by chance alone.
Discussion
We report for the first time a genome-wide survey of DNA methylation
status of skeletal muscle DNA from healthy younger versus older male
individuals. We determined that differentially methylated CpG nucleo-
tides predominantly arise intragenically and are underrepresented in
promoters and are overrepresented in the middle and 3′ end of genes.
We also identified a number of sites that discriminated with high
confidence the younger subjects from older subjects.
Historically, it has long been known that DNA methylation changes
with age to varying extents, dependent upon the sites being assayed
within the genome, species, tissue, or cell (Calvanese et al., 2009).
Several recent studies have reported genome-wide increases in DNA
hypermethylation with age in cells from whole blood or skin (Gr€onniger
et al., 2010; Rakyan et al., 2010; Bell et al., 2012), saliva (Bocklandt
et al., 2011), and brain (Hernandez et al., 2011). Other studies have
reported substantial decreases in DNA methylation with age in blood
(Teschendorff et al., 2010; Heyn et al., 2012). These genome-wide
studies have used a variety of approaches to cover the genome to a
greater or lesser extent, and true genome-wide coverage at the level of
the single base is fast approaching. We have compared the dmCpG sites
we identified in postmitotic human skeletal muscle to the reported
dmCpG sites from six other studies of different tissues. We did not find
any common dmCpG site with age in skeletal muscle (this study) and
brain (Hernandez et al., 2011). With four of these (Rakyan et al., 2010;
Teschendorff et al., 2010; Bocklandt et al., 2011; Bell et al., 2012),
there were only 2–6 dmCpG sites in common (Table S11, Supporting
Information). We identified 141 concordant dmCpG sites between aged
skeletal muscle and blood (Heyn et al., 2012) (Fig. S11, Supporting
Information). The technology for identifying dmCpG sites has rapidly
evolved over the last few years, progressing from relatively low-
throughput assessment of single sites of interest to more than
450 thousand (450 K) sites throughout the genome. We and others
(Heyn et al., 2012) employed the 450 K Illumina array technology to
identify differentially methylated sites with age, while other studies
(Rakyan et al., 2010; Teschendorff et al., 2010; Bocklandt et al., 2011;
Bell et al., 2012) have used the smaller 27 K Illumina platform, surveying
< 6% of the total sites present on the 450 K chip. The difference in the
number of methylation sites being surveyed between the 27 K and
450 K formats could be a major contributory factor with regard to a lack
of concordance between studies, because only three CpG sites from 141
dmCpGs we identified were also present on the smaller format 27 K
Illumina array chip. Interestingly, one CpG site was differentially
methylated with age in three studies (including this study), another
two CpG sites in four studies, and one CpG in five studies. Each of the
methylation sites of interest is located intragenically close to the 5′ end
of four genes. The genes containing these CpG sites are CELF6,
NHLRC1, CECR6, and INSM2. There is little functional information
known about CECR6 or INSM2; however, NHLRC1 encodes the subunit
E3 ubiquitin ligase and is associated with Lafora epilepsy (Salar et al.,
2012). CELF6 is a member of CELF protein family, which carries an RNA-
binding domain.
For genes with two or more intragenic dmCpG sites identified in DNA
from aged skeletal muscle, we have identified several associated gene
ontology terms and pathways which were enriched within the aged
group versus the young subjects, including ‘axon guidance signaling’.
Differential methylation changes in this pathway were used as a focus to
identify how epigenetic changes during aging could potentially relate to
the well-known loss of skeletal muscle function with increasing age.
Motor unit loss (denervation) occurs with aging and is a major
contributory factor in sarcopenia (Doherty et al., 1993). Therefore,
regulation and signaling at the interphase between the nervous system
and the musculature is of critical importance during aging to guide the
motor neuron to the muscle fiber. Within the ‘axon guidance pathway’
ontology, the gene with the highest number of intragenic dmCpG sites
was the NFATC1 (nuclear factor of activated T cells, cytoplasmic 1 gene).
This gene contained 17 dmCpG sites in aged skeletal muscle: 16
hypermethylated and one hypomethylated (Table S7). NFATC1 has an
established role in transcriptional regulation of skeletal muscle in direct
response to electrical stimulation via calcium/calmodulin signaling
(McCullagh et al., 2004; Rana et al., 2008). NFATC1 regulates both
signaling at the neuromuscular junction and acts as a nuclear transcrip-
tional regulator of muscle fibers relating information about the
contractile electrical impulses entering the cell via motor neurons
(Salanova et al., 2011). Methylation changes in the DNA for this gene
and others within the axon guidance signaling pathway may alter
transcriptional events leading to the loss of proper reinnervation at the
neuromuscular junction during muscle turnover. The loss of this plasticity
mechanism has been shown to be a critical step preceding muscle
wasting in both animal models and humans (Lauretani et al., 2006; Chai
et al., 2011; Jang & Van Remmen, 2011). Therefore, the intragenic
differential methylation data we identified in DNA from aged skeletal
muscle provide potential candidate genes for investigating the role of
denervation of the neuromuscular junction loss prior to age-related
muscle loss and sarcopenia. This provides a potential functional linkage
between epigenetic changes in aged muscle tissue and loss of muscle
mass.
In aging human skeletal muscle, we identified a strong preference for
the dmCpG sites to localize within a gene, and in the central and 3′ end
regions of genes, but surprisingly no preference for the promoter. Some
studies have suggested that intragenic DNA methylation could regulate
alternative splicing (Sati et al., 2012) and may be involved in the
regulation of alternative splicing in differentiation and cancer (Irizarry
et al., 2009). These sites may be also important for gene regulation as
they can potentially modulate alternative promoter activity (Maunakea
et al., 2010). We also identified similar results within CGI, where
dmCpGs are overrepresented in intragenic CGI and underrepresented in
CGI that overlap the transcriptional start site. Another possible reason
for the preferential distribution of dmCpG within DNA of aging skeletal
muscle may relate to a potential protective mechanism, where some
areas of the genome are more vulnerable to differential methylation
than others. Partial evidence for this hypothesis is provided by the
observation that promoters without CGI were overrepresented with
dmCpG compared to the CGI promoters. It has been previously reported
that weak CGI promoters tend to be de novo methylated preferentially in
somatic cells during differentiation (Weber et al., 2007). Promoters with
CGI and positive GC-skew are more protected from methylation and de
novo methylation; CGI and GC-skew promoters, however, are less
protected from methylation; and finally, promoters with weak CGI and
week GC-skew showed little to no protection (Ginno et al., 2012). The
overall conclusions of these prior studies on targeted protection are
concordant with the observations we report here on DNA from aging
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human skeletal muscle, where we found less than expected dmCpG
events in CGI-positive GC-skew promoters compared to promoters
without CGI and CG-skew.
A potential issue with the biopsy procedure used in our study is tissue
heterogeneity between biopsies, which may impact the resultant
molecular signatures. There are other cell types in muscle that might
contaminate muscle-specific methylation signatures. Such sample vari-
ation may influence the results. However, it was previously demon-
strated that there is remarkably little technical variation between discrete
biopsies sampled from the right and left leg of the same individual with
regard to fiber type differences, gene expression as assessed by
microarray, fiber size, or even strength (Tarnopolsky et al., 2007).
In summary, we describe for the first time a genome-wide DNA
methylation survey of a postmitotic tissue between young and old
healthy human skeletal muscle. We also determined that there were
several hundred robust dmCpGs that discriminated younger males from
older males. Ontology analysis of the terms associated with dmCpGs
provided several interesting hints of a potential role for epigenetic
changes in the neuromuscular junction during aging. Resistance exercise
can reverse specific aspects of the gene expression changes in aging to
more youthful levels (Melov et al., 2007). Acute endurance exercise has
also been shown to decrease promoter methylation in human skeletal
muscle (Barres et al., 2012). Collectively, this prior work in combination
with the data we report here shows a dynamic inter-relationship
between DNA methylation, gene expression, age, and exercise. With
exercise, gene expression and DNA methylation can both be ‘reversed’,
emphasizing the importance of determining the mechanisms of the
beneficial effects of exercise. Future studies will be needed to determine
whether resistance exercise alters DNA methylation and can reverse the
age-specific methylation profiles we report here.
Experimental procedures
All methods and experimental procedures are available in online
supplement.
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